Primary Biliary Cirrhosis Article Index for
Primary
Website Links For
Primary
 

Information About

Primary Biliary Cirrhosis




  ICD10 K743
  ICD9


Primary biliary cirrhosis is an Autoimmune Disease of the Liver marked by the slow progressive destruction of the small bile ducts within the liver. When these ducts are damaged Bile builds up in the liver ( Cholestasis ) and over time damages the tissue. This can lead to scarring, Fibrosis , Cirrhosis , and ultimately Liver Failure . It is a rare disease, about 200 out of a million; 10 to 1 women to men, although different references vary widely on these numbers.


SIGNS AND SYMPTOMS

The following signs may be present in PBC:


DIAGNOSIS

To diagnose PBC, distinctions should be established from other conditions with similar symptoms, such as Autoimmune Hepatitis or Primary Sclerosing Cholangitis (PSC).

Diagnostic Blood Test s include:

Abdominal Ultrasound or a CT Scan is usually performed to rule out blockage to the bile ducts. Previously most suspected sufferers underwent a Liver Biopsy , and - if uncertainty remained - Endoscopic Retrograde Cholangiopancreatography (ERCP, an Endoscopic investigation of the Bile Duct ). Now most patients are diagnosed without invasive investigation since the combination of anti-mitochondrial antibodies (see below) and typical (cholestatic) liver function tests are considered diagnostic.


ETIOLOGY

The cause of the disease is unknown at this time, but research indicates that there is an Immunological basis for the Disease , making it an Autoimmune Disorder . Most of the patients (>90%) seem to have auto-mitochondrial antibodies (AMAs) against Pyruvate Dehydrogenase complex (PDC-E2), an enzyme that is found in the Mitochondria .


THERAPY

There is no known cure, but medication may slow the progression so that a normal lifespan and quality of life may be attainable for many patients. However, specific treatment for fatigue, which may be invalidating in some patients, is unavailable. Ursodeoxycholic Acid ( Ursodiol ) is one, which helps reduce the cholestasis. To relieve itching caused by bile acids in circulation, which would normally be removed by the liver, Cholestyramine (a Bile Acid Sequestrant ) may be prescribed to absorb bile acids in the gut and be eliminated, rather than re-enter the blood stream. As in all liver diseases, Alcoholic Beverage s are contraindicated. In advanced cases, a Liver Transplant , if successful, results in a favourable prognosis.


REFERENCES


Medical



General



EXTERNAL LINKS